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Endogenous  pyrogen  (EP), 1 the  product  of stimulated  cells  which  mediates 
experimental  fever (1),  was first believed to originate only from polymorphonu- 
clear  (PMN)  leukocytes (2).  The  mechanisms  by which these cells produce EP 
have been studied in several laboratories,  first using cells from rabbit peritoneal 
exudates (3,  4) or leukocytes from rabbit blood (5). After it was discovered that 
human  blood leukocyte pyrogen produces fever in rabbits  (6),  assays based on 
this activity were developed (7, 8), and have been used to examine in some detail 
the mechanism of pyrogen production by human blood leukocytes stimulated in 
vitro by phagocytosis (9,  10). 
Recently,  menonuclear  cells  of  varying  types  have  been  shown  to  release 
pyrogen after stimulation.  Such cell types include human blood monocytes (11), 
rabbit peritoneal macrophages (12), lung macrophages (13), and phagocytic cells 
of  liver  (14),  spleen  (13),  and  lymph  node  (13).  Although  monocytes  and 
peritoneal  macrophages  produce  larger  amounts  of  pyrogen  than  do  PMN 
leukocytes  (11,  12),  little  is known  about the  processes by which  mononuclear 
cells  produce  pyrogen.  The  following  studies  were  therefore  undertaken  to 
examine  the  characteristics  of cell  activation,  and  production  and  release  of 
pyrogen by human  blood monocytes. 
Materials  and  Methods 
All materials, glassware, and reagents used in these studies were made sterile and pyrogen-free, 
usually by heating at 160°C for 2 h or autoclaving for 90 rain. Materials which were not heat-stable 
were sterilized by passage through a  Millipore filter  (Swinnex-25, Millipore Corporation, Bedford, 
Mass.) and tested ibr pyrogenicity either by direct injection into rabbits, or by incubation with blood 
leukocytes and subsequent injection of incubation supernate. 
Pyrogen  Assay.  Techniques  for  injection  and  temperature  monitoring  of  rabbits  were  as 
described previously (8).  Usually, supernates from 2-4  ×  l0  s monocytes constituted a  single assay 
dose. In most experiments, supernates from all samples were injected into the same group of rabbits. 
* This investigation was supported by grants A1-01564-17 and CA-14655-01 from the National 
Institutes of Health, U. S. Public Health Service. 
1  Abbreviations  used  in this paper:  EP, endogenous pyrogen; PMN, polymorphonuclear. 
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Quantification of results, and computation of derived AT were as described previously (8) (see also 
Results). Derived AT is expressed per 1 ×  107 monocytes. 
Preparation o[ Monocytes.  Heparinized  blood  (10 U  heparin/ml)  was  drawn  by venipuncture 
from normal donors. 100-120 ml was added to 3 vol of saline, stirred slowly with a  magnetic stirring 
bar,  and  the  mixture  layered  by  siphoning through  polyethylene  intravenous  tubing  over  8-ml 
Ficoll-Hypaque (15) in 40-ml centrifuge tubes. In some experiments, platelets were first removed by 
centrifuging the blood at 200 g  for 20 rain, separating platelets from the plasma supernate during 
another centrifugation at 2,000 g  for 30 min, and then recombining plasma and blood cells before 
mixing with saline. After the rings of monocytes and lymphocytes had been obtained, the cells were 
washed once in heparinized Krebs-Ringer phosphate buffer, and the buttons resuspended in 6-8 ml of 
Eagle's Minimum Essential Medium (MEM; Auto-POW,  Flow Laboratories,  Inc., Rockville, Md.). 
Numbers of cells were determined with a  Coulter particle counter,  model ZF (Coulter Electronics, 
Inc., Hialeah, Fla.), and differential smears were made. 
Monocyte Incubation.  Aliquots of 3  ×  107 cells (20-30% monocytes,  70-80% lymphocytes) were 
suspended in 5 ml of 15% homologous serum-MEM, and placed in 30-ml tissue culture flasks (Falcon 
Plastics,  Div.  of  BioQuest,  Oxnard,  Calif.).  After  brief exposure  to  COs  in  air,  the  flasks  were 
incubated in a  humidified 5% CO2  atmosphere at 37°C for varying times. At intervals, supernates 
were removed with a Pasteur pipette, and fresh medium placed in the flasks. Counts and differentials 
indicated that about 80% of the lymphocytes were removed at the time of the first medium change. 
When required,  remaining nonadherent lymphocytes were removed by rinsing the monolayers with 
five changes of MEM. In some experiments, nonadherent cells were recovered by centrifugation at 
150 g  for  10 min, and either returned to the monocyte monolayers or incubated alone in separate 
flasks, at a  concentration of 2  ×  106 cells/ml. Nonadherent cells are referred to as lymphocytes. All 
supernates were prepared for injection by centrifugation at 1,000-2,000 g for 20-40 min. They were 
cultured to confirm sterility, and stored at 4°C for 1-7 days before assay (8). 
To  prepare a  pool of monocyte pyrogen,  cells from three donors were obtained (total 9.1  ×  107 
monocytes),  incubated overnight with heat-killed staphylococci, and supernates tested for pyrogen 
content and sterility.  All supernates were then pooled,  divided into appropriate doses in separate 
tubes, and frozen at  -20°C until use. An average minimal pyrogenic dose for a rabbit (AT >_ 0.3°C) 
was calculated to be derived from 8  ×  105 monocytes. 
Cells in tissue culture flasks were observed daily by light microscopy. In some experiments cells 
were  incubated on cover slips in small Petri dishes, and at various time intervals cover slips were 
rinsed,  fixed in buffered formalin or glutaraldehyde for 30 rain, or mounted without fixing, and ex- 
amined by phase microscopy. 
Cell-Asociated Pyrogen.  For  assay  of  cell-associated  (intracellular)  pyrogen  content,  after 
appropriate incubation, cell monolayers were rinsed three times with MEM, a small volume of fresh 
medium  added,  and  the  flasks  placed  at  -20°C.  Subsequently  the  cells  were  disrupted  by 
freeze-thawing 5 times by alternating placement of the flasks at -20 ° or 37°C. Supernatant medium 
was then removed and the flask surface was rinsed vigorously with an additional volume of fresh 
medium. All fluids obtained were centrifuged at 2,000 g  for 20 rain and the supernates assayed for 
pyrogen content, as above. 
Reagents.  A  particle-free preparation of endotoxin was  prepared by centrifugation of typhoid 
vaccine (Monovalent Reference Std. NR V-LS no. 1) at 20,000 g for 1 h. Clear supernate contained 
about 10 pyrogenic doses per ml (average AT 1.0°C per dose). Heat-killed Staphylococcus albus was 
prepared as described previously (9); 20-30 bacteria per monocyte were added to flasks. Puromycin 
HCI was prepared as described previously (9),  and added to final concentrations of 0.8,  or 5  ×  10- ~ 
M. 
Results 
Assay  of Monocyte  Endogenous  Pyrogen.  In  order  to  determine  the  dose- 
response  characteristics  of human  monocyte  pyrogen  assayed  in rabbits,  a  pool of 
pyrogen-containing  supernate  was  prepared  from  monocytes  stimulated  with 
heat-killed  staphylococci  (see Methods).  Average  temperature  responses  in seven 
rabbits  to  injection  of two  doses  of this  pooled  pyrogen  are  presented  in Fig.  1. 956  HUMAN MONOCYTE PYROGEN 
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FIG.  1.  Average temperature responses in the same seven rabbits after injection of monocyte 
pyrogen at two doses. Total range of peak responses at 45 min is shown. Supernate per rabbit 
was derived from 1.2  ×  106 monocytes (A) or 3  ×  107 monocytes (B). 
The  response  is  monophasic,  with  the  peak  temperature  elevation  occurring 
between 45 and 60 min after injection; these characteristics are the same as those 
previously reported for human blood leukocyte (PMN) pyrogen (6). 
The dose-response data are presented in Fig. 2 a and b. Maximum temperature 
responses are plotted against increasing doses of pyrogenic supernate, on a linear 
(a)  and  semilogarithmic  (b)  scale.  The  results  again  closely resemble  those 
obtained  previously  with  human  PMN  leukocyte  pyrogen  (8),  except  that 
equivalent pyrogenic responses (average AT 0.6°C) were obtained with supernate 
from 2  x  108  monocytes compared to 3  ×  107  PMN  leukocytes. Although the 
temperature responses to  10-fold  increased doses of monocyte pyrogen follow a 
logarithmic curve, as determined by statistical tests for trend, 2 the lower portion 
of the  curve (average  AT from 0.3°-0.9°C)  is  linear (see Fig. 2 a).  This range, 
therefore,  was  used  routinely  to  estimate  pyrogenic  content  of experimental 
supernates. 
Endogenous Pyrogen Assay After Cell Stimulation by Endotoxin.  Monocytes 
stimulated with endotoxin adhered well to plastic or glass, unlike cells stimu- 
lated  by  phagocytosis,  and  were  therefore  convenient  cells  to  use  for  timed 
studies  of pyrogen  release.  Tests  were  done  to  determine whether endotoxin 
would  confuse  the  assay  for  EP  produced  during  the  incubation.  When  the 
maximum dose of endotoxin was mixed with medium and injected into rabbits 
moderate  pyrogenicity  was  observed  (average  AT  0.58°C  in  eight  rabbits). 
However, after the same dose was incubated with cells for 2-3 h, no significant 
pyrogen remained in the supernate (average AT 0.14°C in seven rabbits). Similar 
rapid disappearance of endotoxin has been observed with blood (16) and exudate 
(17) PMN leukocytes. In addition, pyrogen released by or present in monocytes 
after 8- or 18-h incubations with endotoxin was tested in rabbits before and after 
they were rendered tolerant to endotoxin by a single, large injection of typhoid 
2 Kindly performed by Dr. Grace Wyshak. PHYLLIS BODEL  957 
AT 
(°C) 
1.5 
1.0 
0.5 
CI 
I  I  I  I  i  I  I  I  I 
1  2  5  4-  5 
DOSE  (x)  OF  MONOCYTE  PYROGEN 
I 
10 
AT 
(°C) 
0.5 
1.5  13 
1.0 
/ 
i  i  i 
0  2  5  5 
J 
i 
lO 
DOSE  (x)  OF  MONOCYTE PYROGEN 
FIG.  2.  (a)  Average  maximum height of fever in  the  same seven rabbits after injection  of 
increasing doses  of monocyte  pyrogen,  lx  -  10×,  where  1×  is  a  minimal pyrogenic dose 
derived from about 8  x  10 ~ monocytes (see Methods). Total range of responses is enclosed in 
brackets. (b) The same data are plotted with log dose on the abscissa. The best line describing 
the curve was determined by the method of least squares. 
vaccine  (18).  Pyrogenicity of the  solutions  was  not  changed  in  the  tolerant 
animals. Under these experimental conditions, therefore, endotoxin apparently 
does not confuse the assay for EP. 
Effect  of  Incubation  Conditions  on  Pyrogen  Release.  In  initial  studies, 
monocytes were stimulated with endotoxin or phagocytosis, and incubated either 958  HUMAN  MONOCYTE  PYROGEN 
in shaking Erlenmeyer or stationary tissue culture flasks for 18 h. Cells to which 
staphylococci had  been added  produced two or three times as much pyrogen as 
did  those  stimulated  with  endotoxin.  Monocytes fixed to  plastic  produced  the 
same  amounts  of  pyrogen  as  did  cells  suspended  in  a  shaking  system.  Cells 
incubated  without  stimuli  in  either  system did  not  release  pyrogen,  except  on 
rare  occasions.  Monocytes  maintained  in  tissue  culture  flasks  without  added 
stimuli  for up  to  5  days also did not  contain  detectable  pyrogen,  nor release it 
spontaneously,  even though  they were observed to enlarge,  spread,  and become 
increasingly vacuolated,  as described by others  (19). 
Time  Required  for  Cell Activation.  Monocyte  monolayers were  exposed  to 
endotoxin  for  15,  45,  or  90  min.  Endotoxin-containing  medium  was  then 
discarded,  fresh medium added to flasks, and the incubation continued for 18 h. 
One set of flasks was incubated with the original endotoxin medium for 18 h. All 
supernates  were  then  assayed  for  pyrogen.  The  results  are  shown  in  Table  I. 
TABLE  I 
Effect of Time of Incubation with Endotoxin on Monocyte Pyrogen Production 
Incubation with endotoxin 
0 min  15 min  45 min  90 min  18 h 
AT(°C) + SEM* 
Pyrogen in 18-h super-  0.10 ± 0.02  0.12 ± 0.04  0.50 ± 0.08  0.58 ± 0.08  0.67 ± 0.07 
nate 
* Average of eight assays each. 
Although  a  15-min exposure to endotoxin  was not sufficient to initiate  pyrogen 
production,  45-min and 90-min exposures were almost as effective as incubation 
for  18  h  with  endotoxin.  These results  indicate  that  monocytes require  only 45 
min of contact with  medium  containing  endotoxin  in order to produce pyrogen 
subsequently.  Similar results were obtained when phagocytosis of staphylococci 
was used  as the stimulus. 
Effects of L ymphocytes on Pyrogen Production by Monocytes.  Since lympho- 
cytes can influence  the function of monocytes or macrophages in other systems 
(20-23),  the  role  of lymphocytes  in  the  initiation  or  continuation  of pyrogen 
production  was  examined.  Initial  experiments  showed  that  flasks  from  which 
lymphocytes had  been  removed by repeated  washings  produced  as much  pyro- 
gen following addition of either endotoxin or staphylococci as did flasks contain- 
ing  10- 20% lymphocytes. To examine this question further,  two types of experi- 
ments were done. 
In the first, lymphocytes were incubated with endotoxin for 1-2 h  before being 
added  to  monocyte monolayers,  to  determine  whether  such  lymphocytes could 
initiate  pyrogen  production  by  monocytes.  After  exposure  to  endotoxin,  the 
lymphocytes were washed twice and suspended in fresh medium to remove traces 
of endotoxin.  Other lymphocytes were treated  similarly,  but endotoxin  was not 
added. To some flasks of monocytes no lymphocytes were returned but endotoxin 
was added directly. After 16 h, pyrogen content of all supernates was measured. PHYLLIS  BODEL  959 
The results are shown in Table II. Preincubation of.lymphocytes  with endotoxin 
did not result in significant pyrogen production by monocytes when the two cell 
types were subsequently incubated together. Thus no evidence was obtained that 
lymphocytes mediate activation of monocytes by endotoxin. 
To examine the influence of lymphocytes on continuing pyrogen production by 
monocytes, flasks containing both cell types were incubated with staphylococci 
or endotoxin for 2-3 h.  Supernatant fluid and nonadherent cells were then re- 
moved from all flasks, and fresh incubation medium returned; to some flasks, the 
nonadherent  cells  were  returned.  Other  aliquots  of lymphocytes were  resus- 
pended  in the original or  fresh medium and  incubated separately. After  16 h, 
pyrogen  content  of  all  supernates  was  measured.  The  results  of  four  such 
experiments with endotoxin, shown in Table III, indicate that pyrogen release by 
monocytes was not altered when lymphocytes were present. Thus, there was no 
apparent  effect of lymphocytes on  the  continuing production  of pyrogen  by 
monocytes. 
Stability of Monocyte Pyrogen During Incubation.  EP from PMN leukocytes 
retains most of its activity during overnight incubation at 37°C, pH 7.4  (8).  EP 
from  monocytes was  similarly tested. Pyrogen-containing supernate,  collected 
from cells stimulated by phagocytosis, was assayed for pyrogen content. Aliquots 
were  then  reincubated  for  18  h,  either  alone  or  with  cells  which  had  been 
stimulated by endotoxin or phagocytosis during the preceding 24 h. The results of 
TABLE II 
Failure of Endotoxin-Exposed Lymphocytes to Stimulate Monocyte Pyrogen Production 
Monocytes  Monocytes +  Monocytes +  Endotoxin- 
endotoxin-  endotoxin 
÷ normal  treated 
treated  (lymphocytes 
lymphocytes  lymphocytes  removed)  lymphocytes 
AT(°C) ± SEM* 
Pyrogen in 18-h supernates  0.12 ± 0.03  0.24 ±  0.08  0.89 ± 0.12  0.17 ± 0.07 
* Average of eight assays each, using the same eight rabbits. 
TABLE III 
Effect of Lymphocyte Removal on Pyrogen Production by Monocytes 
Stimulated with Endotoxin 
Monocytes 
with 
Monocytest  lymphocytes  Lymphocytes 
returned 
•T(°C)  ± SEM* 
Pyrogen in 18-h supernate  0.59 ± 0.07  0.58 ± 0.07  0.09 ± 0.03 
* Average of 9  17 assays each. 
t Nonadherent cells and medium removed 2-3 h after addition of endotoxin. See 
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three such experiments are presented in Table IV. No significant loss of activity 
was observed when pyrogen-containing supernate was incubated at 37 ° for 18 h, 
compared  to  aliquots  stored  at  4°C.  When  supernate  was  reincubated  with 
monocytes,  little  pyrogenic activity was lost.  Previously stimulated  monocytes, 
incubated  alone  in  fresh  medium,  produced  insignificant  amounts  of pyrogen 
when  tested  at this  dosage  (right-hand  column,  lower row).  Thus,  most of the 
pyrogenic  activity  of  monocyte  pyrogen  appears  to  be  retained  during  18-h 
incubation  both  with  previously  stimulated  cells  and  with  products  initially 
released  by these  cells,  which  are  present  in  the  pyrogen-containing supernate 
itself.  Consequently,  investigation  of the  dynamics  of pyrogen production  and 
release from monocytes appeared feasible. 
Rate  of  Pyrogen  Production  and  Release.  Studies  were  carried  out  to 
determine  the  rate  at  which  pyrogen  is  produced,  released,  or  retained  in 
monocytes  after  stimulation  by nonparticulate  endotoxin.  The  results  of these 
TABLE IV 
Stability o/Monocyte Pyrogen During Incubation 
4°C 
18-h incubation (37°C) 
With  Alone  monocytes 
AT(°C) + SEM* 
Pyrogen-containing  0.83 ± 0.08  0.81 ± 0.07  0.68 ± 0.09 
supernate 
Fresh medium  --  --  0.17 ± 0.05 
* Average of 8-12 assays each. 
studies  are  shown  in  Fig.  3.  The  cumulative  pyrogen content  of the incubation 
medium, removed at different times during incubation,  is shown on the left, and 
cell-associated  pyrogen content  at  the  specified times  on the right.  Significant 
pyrogen is not detectable within or without the cell for up to 3 h after stimulation. 
After  this,  increasing  amounts  appear  in  the  incubation  medium;  significant 
pyrogen  release  was  sometimes  observed  up  to  36-48  h  after  the  start  of 
incubation, but rarely thereafter. Levels of detectable cell-associated pyrogen are 
absent initially,  but rise to moderate levels during the  18-h incubation. 
Requirement for Protein Synthesis.  To investigate the importance of protein 
synthesis  on  continuing  production  and  release  of  pyrogen  by  monocytes, 
puromycin  0.8,  2,  or  5  ×  10 -6  M  was  added  to  cells  at  varying  times  after 
endotoxin,  and  supernatant  and  cell-associated  pyrogen  were  assayed  after 
further  incubations.  The  results  of  studies  with  2  ×  10 -~  M  puromycin  are 
presented in Fig. 4. Addition of puromycin at the beginning of incubation, as well 
as 3 h  afterwards, significantly inhibited  pyrogeri release. This later effect could 
not be due to interference with cell activation, since, as noted above, the presence 
of endotoxin  in  the  medium  after  1  h  of incubation  is  not  needed  for  normal 
pyrogen  production  to  occur  subsequently.  Experiments  were  also  done  to 
measure  levels of cell-associated  pyrogen  in  the  presence  of puromycin.  When 
tested  after  8  h  incubation  with  endotoxin,  normal  cells  contained  significant PHYLLIS BODEL  961 
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amounts of pyrogen (average derived AT 0.96°C,  as shown in Fig. 3),  whereas 
cells incubated with endotoxin and puromycin contained no detectable pyrogen 
(average  derived  AT  0.16°C,  six  assays).  These  results,  then,  indicate  that 
monocytes require  late  protein  synthesis,  after  activation  and  early  pyrogen 
production has begun, in order for production of pyrogen to continue normally. 
Discussion 
Although PMN leukocytes were originally believed to be the sole source of EP, 
recent work has shown that several mononuclear cell types can produce pyrogen. 
Human blood monocytes (11),  lung macrophages (13),  and tissue mononuclear 
cells of liver (14),  spleen, and lymph nodes (13) released pyrogen in vitro after 
stimulation by endotoxin, phagocytosis, or an antigen such as old tuberculin. 
When incubated in saline, rabbit peritoneal exudate monocytes released pyrogen 
even without a specific stimulus (12). Presumably these cells, like exudate PMNs 
(24),  have been activated in vivo. Both blood (11) and exudate (12) monocytes 
produced larger amounts of' pyrogen than did blood or exudate PMNs. 
The  results  reported  here  define  certain  characteristics  of  the  process  of 
pyrogen production by human blood monocytes. Like PMN leukocytes (9), these 
cells contain no detectable pyrogen at the time of harvest from blood, and if the 
cells  are  not  stimulated,  pyrogen production does not occur.  Also,  like PMN 
leukocytes (7,  9,  10), pyrogen production from monocytes begins within several 
hours after stimulation, requires only a short interval of contact with activator, 
and is prevented if puromycin is added initially. The pyrogen produced, like that 
from PMN leukocytes (8),  loses little activity during incubation at 37°C, pH 7.4, 
even in the presence of activated cells or their products. 
Several  differences, however,  were  noted between production of pyrogen by 
monocytes and by PMN leukocytes. Monocytes produced 10-15  times as much 
pyrogen as equal numbers of PMN leukocytes. Furthermore, production contin- 
ued  for  up  to  36  h,  unlike  pyrogen  production  by  PMN  leukocytes,  which 
continued for only 12-16  h  (9,  1O). Finally, continuing production of pyrogen by 
monocytes  was  inhibited  by  low  concentrations  of'  puromycin  (<1  #g/ml), 
whereas fivefold and 20-fold higher concentrations of this inhibitor had no effect 
on  production  of  pyrogen  by  PMN  leukocytes,  once  initial  activation  had 
occurred  (9,  10). Although  puromycin  at  1  ttg/ml  is  eventually  lethal  for 
macrophages  in  tissue  culture  (25),  and  caused  rounding and  detachment of 
monocytes after  overnight  incubation  in  these  experiments,  such  effects  are 
delayed,  whereas  inhibition  of pyrogen  production  occurred  within  hours.  In 
addition, at a sublethal concentration of 0.4 ttg/ml (25), puromycin also partially 
inhibited late pyrogen synthesis by monocytes. These results suggest that the 
observed effects of puromycin are probably not due to nonspecific toxicity, but 
represent  a  requirement for continued protein synthesis by pyrogen-producing 
monocytes.  Unlike  stimulated  PMN  leukocytes,  therefore,  which  have  only 
an early requirement for protein synthesis, stimulated monocytes may continu- 
ously synthesize pyrogen molecules during incubation. Such a process would be 
consistent  with  morphologic  (19, 26)  and  biochemical  (19) evidence  that 
monocytes synthesize many proteins,  including lysosomal enzymes. Mononu- PHYLLIS  BODEL  963 
clear phagocytes in vitro both synthesize and release complement components, 
interferon, and transferrin (27). 
Monocytes (19}, as well as macrophages {28), mature during culture in vitro to 
cells which have been called "activated," since they contain increased concentra- 
tions  of  enzymes,  and  exhibit  heightened  activity,  including  pinocytosis, 
phagocytosis, and various metabolic reactions. It was expected that such cells 
might  also  begin  to  synthesize  pyrogen,  since  this  is  a  normal  response  of 
stimulated phagocytic cells.  However,  monocytes maintained in culture for as 
long  as  5  days never  spontaneously produced  pyrogen,  nor  did  they contain 
detectable  amounts.  This  finding  suggests  that  stimuli  leading  to  pyrogen 
production  can  be  differentiated from  those  leading  to  cell  maturation,  or 
"activation." 
No evidence was found to implicate blood lymphocytes in either activation or 
continuing production of pyrogen by monocytes. In other systems, lymphocytes 
alter both the morphology and function of monocytes or macrophages (20-23). In 
an in vitro model of delayed hypersensitivity fever, pyrogen release from blood 
cells  was  related to specific  interactions between antigen,  sensitized lympho- 
cytes, and some pyrogen-producing cells in the blood (29).  Similar interactions, 
however,  were  not  observed  when  usual doses  of endotoxin were  used  as  the 
activator {30). Our data suggest that lymphocytes are not necessary intermedi- 
ates in the processes of monocyte activation or pyrogen production, either by a 
nonparticulate  preparation  of  endotoxin,  or  by  phagocytosis  of  heat-killed 
bacteria.  However,  a  few  lymphocytes  remain  with  monocytes  under  the 
conditions of our experiments (31), and the possibility that these few cells play an 
important role cannot be excluded. 
Several  lines  of evidence  suggest  that  pyrogen  from  mononuclear  cells  is 
important  in  both  experimental  and  clinical  fevers.  Studies  of  endotoxin 
tolerance in rabbits, both in vitro (14) and in vivo (32), implicated Kupffer cells, 
rather than blood cells, in the failure of tolerant animals to develop fever after i.v. 
injection of endotoxin. In man, high fevers are characteristic of granulocytopenic 
states, such as acute monocytic leukemia and agranulocytosis, and of granuloma- 
tous diseases in which inflammatory lesions contain predominantly mononuclear 
cells  (1).  Spleen and lymph node tissues from patients with Hodgkin's disease 
frequently produce  pyrogen in  vitro;  experimental results  suggest that  tissue 
mononuclear cells are the source of this pyrogen in many instances (33). Human 
mononuclear cell pyrogen has a  larger molecular weight than PMN  leukocyte 
pyrogen (34), and is produced for a longer time (33, and results above). Thus, the 
sustained fevers characteristic of many diseases in which malignant or inflamma- 
tory mononuclear cells are predominant may be due to prolonged release of this 
pyrogenic protein by activated monocytes or macrophages in situ. 
Summary 
The  characteristics of pyrogen production and release by human blood mono- 
cytes were investigated. A dose-response assay of monocyte pyrogen in rabbits 
indicated a  linear relationship of temperature elevation to dose of pyrogen at 
lower doses. Monocytes did not contain pyrogen when first obtained, nor did they 964  HUMAN  MONOCYTE  PYROGEN 
release  it  spontaneously  even  after  5  days  of  incubation  in  vitro.  Pyrogen 
production was apparent 4 h  after stimulation by endotoxin or phagocytosis, and 
continued  for  24  h  or  more.  Puromycin,  an  inhibitor  of  protein  synthesis, 
prevented both initiation and  continuation of pyrogen production and release. 
Pyrogen-containing supernates  retained  most  pyrogenic  activity during  over- 
night incubation even in the presence of activated cells. Lymphocytes appeared 
to play no role in either initiation or continuation of pyrogen production in these 
studies. 
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